Rebus Holdings, Inc. (RBSH)

Market Cap	32.00
Revenue (ttm)	n/a
Net Income (ttm)	570.00K
Shares Out	32.13M
EPS (ttm)	0.02
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,657
Open	n/a
Previous Close	0.0001
Day's Range	n/a
52-Week Range	0.0000 - 0.0140
Beta	1.10
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Rebus Holdings

Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. Rebus Holdings, Inc. was incorporated in 2003 and is based in Westlake Village, California.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: RBSH